Skip to main navigation Skip to search Skip to main content

A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/ NIRVANA-R trial

  • Junsik Park
  • , Myong Cheol Lim
  • , Jae Kwan Lee
  • , Dae Hoon Jeong
  • , Se Ik Kim
  • , Min Chul Choi
  • , Byoung Gie Kim
  • , Jung Yun Lee
  • Yonsei University
  • National Cancer Center Korea
  • Korea University
  • Inje University
  • Seoul National University
  • CHA Bundang Medical Center

Research output: Contribution to journal › Article › peer-review

20   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/ NIRVANA-R trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry